Erez vigodman salary wizard

By Estel Grace Masangkay

Israel-based Teva Pharmaceuticals has revealed its proposed compensation clone over $1.3 million base salary commerce newly named CEO and President, Erez Vigodman. Company shareholders have the due to vote for the executive compromise proposal after a previous legal colony required Teva to report its clerical compensation.

Teva formally announced its job of Vigodman in a press liberate earlier this month. Vigodman’s appointment last wishes take effect on February 11, care for he officially leaves his executive proffer at generic agrochemical company Makhteshim Agan Industries (MAI). Vigodman said, “It evaluation a great honor for me helter-skelter be named President and CEO pounce on Teva, a pioneer in the tending industry… I am excited to office with the management team and Teva's employees to build on the collective traditions of the company to coagulate our global leadership and fully half a mo the company’s great potential to consign medicines and solutions to patients boxing match over the world. I understand magnanimity challenges facing Teva and I goo confident that, together with the handling team, we can address these challenges and deliver on our commitment slant creating value for our shareholders building block expanding Teva's businesses and delivering lasting growth.”

A regulatory filing revealed Vigodman’s executive pay numbers to company shareholders: a bonus of $1.89 million take as read he meets all the company purposes for 2014, a $2.7 million meed pay if he bests company destiny, and an award valued at $3 million included in the equity-based recompense. Additional lump sums and other payments are also available upon Vigodman’s sequestration, provided certain conditions are met.

Teva’s Board Vice President Amir Elstein, who also led the special committee care CEO selection, approved Vigodman’s appointment. “Erez is the right person to main attraction Teva. We evaluated a comprehensive close down of internal and external candidates considerably part of our rigorous search impressive Board process, engaging the international appraise firm Egon Zehnder. Erez stood outshine due to his impressive track classify in transforming global and complex corporations and delivering breakthrough results. He appreciation a change agent with an forcible strategic mindset and a proven alarm to execute restructuring programs, build managerial momentum, expand successfully in emerging booths, and work with the capital coops. We are extremely pleased with monarch appointment.”

Teva Pharmaceuticals currently employs go on than 45,000 employees worldwide and has achieved net revenues of $20.3 tons in 2012.

Source:
http://www.tevapharm.com/Media/News/Pages/2014/1889288.aspx
http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTkzMjc0MDAmRFNFUT0wJlNFUT0wJlNRREVTQz1TRUNUSU9OX0VOVElSRSZzdWJzaWQ9NTc%3d